Unilever shares fall as it defends £50bn approach for GSK's Aquafresh to Panadol consumer arm

Shares in consumer goods giant Unilever have fallen after it defended its £50bn takeover approach for the consumer healthcare arm of GlaxoSmithKline (GSK), describing the business as a "strong strategic fit".